A Survey On The Increase In Autism Spectrum Disorders Rate And Present Treatments In India
|© 2021 by IJCTT Journal|
|Year of Publication : 2021|
|Authors : Dr. S.Selvi, Mrs.D. Mohanapriya, Dr.P.Thamilselvan, Ms.Shamle Raj.N|
|DOI : 10.14445/22312803/IJCTT-V69I3P111|
How to Cite?
Dr. S.Selvi, Mrs.D. Mohanapriya, Dr.P.Thamilselvan, Ms.Shamle Raj.N, "A Survey On The Increase In Autism Spectrum Disorders Rate And Present Treatments In India," International Journal of Computer Trends and Technology, vol. 69, no. 3, pp. 60-63, 2021. Crossref, 10.14445/22312803/IJCTT-V69I3P111
Autism Spectrum Disorder is dealing with a group of neurodevelopmental disorders, and many are affected by this neuro disorder and have a stereotype interest; moreover, they have a pattern of behavior. This paper contains the information about autism in children and the drugs, treatment given to them, and also the survey list of autism children.
Autism, Neuro Disorder, Insomnia, Receptors, and ASD.
 Food and Drug Administration FDA approves the first drug to treat irritability associated with autism, Risperdal. Oct 6, 2006. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ 2006/ucm108759.htm. Accessed January 27, (2015).
 McCracken JT, McGough J, Shah B, et al., Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314–321. [PubMed] [Google Scholar]
 Abilify (aripiprazole) prescribing information. Princeton, New Jersey: Bristol-Myers Squibb; Dec 2014. Available at: http://www.otsukaus.com/Documents/Abilify.PI.pdf. Accessed January 28, (2015).
 Smith HS, Cox LR, Smith BR., Dopamine receptor antagonists, Ann PalliativeMed. 2012Jul; Available at http://www.amepc.org/apm/article/view/1039/1266. Accessed January 28, (2015).
 Haldol (haloperidol) prescribing information. Raritan, New Jersey: Ortho-McNeil Pharmaceutical, Inc. Jun 2009. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018701s 059lbl.pdf. Accessed January 27, (2015).
 MacDonald K, Wilson MP, Minassian A, et al., A retrospective analysis of intramuscular haloperidol and olanzapine in the treatment of agitation in drug- and alcohol-using patients. Gen Hosp Psychiatry, 32 (2010) 443–445.
 Clinton JE, Sterner S, Stelmachers Z, et al., Haloperidol for sedation of disruptive emergency patients, Ann Emerg Med., 16 (1987)319–322.
 Kosaka H, Munesue T, Ishitobi M, et al., Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry. 12:110. doi: 10.1186/1471-244X-12- 110. [PMC free article] [PubMed] [CrossRef] [Google Scholar] (2012).
 Zoloft (sertraline) prescribing information, New York, New York: Pfizer Inc.; May 2014. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=517. Accessed January 29, (2015). [Google Scholar]
 Bhardwaj A, Agarwal V, Sitholey P., Asperger’s disorder with comorbid separation anxiety disorder: a case report. J Autism Dev Disord, 35 (2005)135–136. [PubMed] [Google Scholar]
 Hollander E, Soorya L, Chaplin W, et al., A double-blind placebocontrolled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders, Am J Psychiatry, 169 (2012) 292–299. [PubMed] [Google Scholar]
 Lee H-J, Macbeth AH, Pagani J, Scott WS., 3rd Oxytocin: the great facilitator of life. Prog Neurobiol, 88 (2009) 127–151. [PMC free article] [PubMed] [Google Scholar]
 Liu JCJ, McErlean RA, Dadds MR., Are we there yet? The clinical potential of intranasal oxytocin in psychiatry. Curr Psychiatry Rev. 8 (2012) 37–48. [Google Scholar]
 Gordon I, Vander Wyka BC, Bennetta RH, et al., Oxytocin enhances brain function in children with autism. PNAS, 110 (2013) 20953– 20958. [PMC free article] [PubMed] [Google Scholar]